CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 1,725 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $1,000 | 0.0% | 1,725 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,000 | -75.0% | 1,725 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $4,000 | -20.0% | 1,725 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | +400.0% | 1,725 | +245.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -93.3% | 500 | -93.3% | 0.00% | -90.9% |
| Q3 2016 | $30,000 | 0.0% | 7,420 | +9.8% | 0.01% | -21.4% |
| Q2 2016 | $30,000 | +30.4% | 6,760 | +12.5% | 0.01% | +40.0% |
| Q1 2016 | $23,000 | -74.4% | 6,008 | +4.6% | 0.01% | -78.7% |
| Q4 2015 | $90,000 | +55.2% | 5,744 | +4.9% | 0.05% | +42.4% |
| Q3 2015 | $58,000 | -58.0% | 5,477 | +0.1% | 0.03% | -50.7% |
| Q2 2015 | $138,000 | -13.2% | 5,472 | -3.9% | 0.07% | -25.6% |
| Q1 2015 | $159,000 | +76.7% | 5,696 | +15.4% | 0.09% | +34.3% |
| Q4 2014 | $90,000 | – | 4,938 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |